Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

被引:0
|
作者
Yoichi Naito
Saori Mishima
Kiwamu Akagi
Ataru Igarashi
Masafumi Ikeda
Susumu Okano
Shunsuke Kato
Tadao Takano
Katsuya Tsuchihara
Keita Terashima
Hiroshi Nishihara
Hiroyki Nishiyama
Eiso Hiyama
Akira Hirasawa
Hajime Hosoi
Osamu Maeda
Yasushi Yatabe
Wataru Okamoto
Shigeru Ono
Hiroaki Kajiyama
Fumio Nagashima
Yutaka Hatanaka
Mitsuru Miyachi
Yasuhiro Kodera
Takayuki Yoshino
Hiroya Taniguchi
机构
[1] National Cancer Center Hospital East,Department of Breast and Medical Oncology
[2] Saitama Cancer Center,undefined
[3] Yokohama City University School of Medicine,undefined
[4] Juntendo University,undefined
[5] Tohoku University,undefined
[6] National Center for Child Health and Development,undefined
[7] Keio University,undefined
[8] Tsukuba University,undefined
[9] Hiroshima University Hospital,undefined
[10] Okayama University,undefined
[11] Kyoto Prefectural University of Medicine,undefined
[12] Nagoya University Hospital,undefined
[13] National Cancer Center Hospital,undefined
[14] Jichi Medical University,undefined
[15] Kyorin University Faculty of Medicine,undefined
[16] Hokkaido University Hospital,undefined
[17] Japan Society of Clinical Oncology (JSCO),undefined
[18] Japanese Society of Medical Oncology (JSMO),undefined
[19] Japanese Society of Pediatric Hematology/Oncology (JSPHO),undefined
关键词
(; ) fusion; Tropomyosin receptor kinase (TRK) inhibitor; Advanced solid tumor; Tumor-agnostic treatment; Clinical practice guideline;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:403 / 417
页数:14
相关论文
共 15 条
  • [1] Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
    Naito, Yoichi
    Mishima, Saori
    Akagi, Kiwamu
    Igarashi, Ataru
    Ikeda, Masafumi
    Okano, Susumu
    Kato, Shunsuke
    Takano, Tadao
    Tsuchihara, Katsuya
    Terashima, Keita
    Nishihara, Hiroshi
    Nishiyama, Hiroyki
    Hiyama, Eiso
    Hirasawa, Akira
    Hosoi, Hajime
    Maeda, Osamu
    Yatabe, Yasushi
    Okamoto, Wataru
    Ono, Shigeru
    Kajiyama, Hiroaki
    Nagashima, Fumio
    Hatanaka, Yutaka
    Miyachi, Mitsuru
    Kodera, Yasuhiro
    Yoshino, Takayuki
    Taniguchi, Hiroya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 403 - 417
  • [2] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
    Naito, Yoichi
    Mishima, Saori
    Akagi, Kiwamu
    Hayashi, Naomi
    Hirasawa, Akira
    Hishiki, Tomoro
    Igarashi, Ataru
    Ikeda, Masafumi
    Kadowaki, Shigenori
    Kajiyama, Hiroaki
    Kato, Motohiro
    Kenmotsu, Hirotsugu
    Kodera, Yasuhiro
    Komine, Keigo
    Koyama, Takafumi
    Maeda, Osamu
    Miyachi, Mitsuru
    Nishihara, Hiroshi
    Nishiyama, Hiroyuki
    Ohga, Shouichi
    Okamoto, Wataru
    Oki, Eiji
    Ono, Shigeru
    Sanada, Masashi
    Sekine, Ikuo
    Takano, Tadao
    Tao, Kayoko
    Terashima, Keita
    Tsuchihara, Katsuya
    Yatabe, Yasushi
    Yoshino, Takayuki
    Baba, Eishi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (07) : 827 - 840
  • [3] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
    Yoichi Naito
    Saori Mishima
    Kiwamu Akagi
    Naomi Hayashi
    Akira Hirasawa
    Tomoro Hishiki
    Ataru Igarashi
    Masafumi Ikeda
    Shigenori Kadowaki
    Hiroaki Kajiyama
    Motohiro Kato
    Hirotsugu Kenmotsu
    Yasuhiro Kodera
    Keigo Komine
    Takafumi Koyama
    Osamu Maeda
    Mitsuru Miyachi
    Hiroshi Nishihara
    Hiroyuki Nishiyama
    Shouichi Ohga
    Wataru Okamoto
    Eiji Oki
    Shigeru Ono
    Masashi Sanada
    Ikuo Sekine
    Tadao Takano
    Kayoko Tao
    Keita Terashima
    Katsuya Tsuchihara
    Yasushi Yatabe
    Takayuki Yoshino
    Eishi Baba
    International Journal of Clinical Oncology, 2023, 28 : 827 - 840
  • [4] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
    Mishima, Saori
    Naito, Yoichi
    Akagi, Kiwamu
    Hayashi, Naomi
    Hirasawa, Akira
    Hishiki, Tomoro
    Igarashi, Ataru
    Ikeda, Masafumi
    Kadowaki, Shigenori
    Kajiyama, Hiroaki
    Kato, Motohiro
    Kenmotsu, Hirotsugu
    Kodera, Yasuhiro
    Komine, Keigo
    Koyama, Takafumi
    Maeda, Osamu
    Miyachi, Mitsuru
    Nishihara, Hiroshi
    Nishiyama, Hiroyuki
    Ohga, Shouichi
    Okamoto, Wataru
    Oki, Eiji
    Ono, Shigeru
    Sanada, Masashi
    Sekine, Ikuo
    Takano, Tadao
    Tao, Kayoko
    Terashima, Keita
    Tsuchihara, Katsuya
    Yatabe, Yasushi
    Yoshino, Takayuki
    Baba, Eishi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (08) : 941 - 955
  • [5] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
    Saori Mishima
    Yoichi Naito
    Kiwamu Akagi
    Naomi Hayashi
    Akira Hirasawa
    Tomoro Hishiki
    Ataru Igarashi
    Masafumi Ikeda
    Shigenori Kadowaki
    Hiroaki Kajiyama
    Motohiro Kato
    Hirotsugu Kenmotsu
    Yasuhiro Kodera
    Keigo Komine
    Takafumi Koyama
    Osamu Maeda
    Mitsuru Miyachi
    Hiroshi Nishihara
    Hiroyuki Nishiyama
    Shouichi Ohga
    Wataru Okamoto
    Eiji Oki
    Shigeru Ono
    Masashi Sanada
    Ikuo Sekine
    Tadao Takano
    Kayoko Tao
    Keita Terashima
    Katsuya Tsuchihara
    Yasushi Yatabe
    Takayuki Yoshino
    Eishi Baba
    International Journal of Clinical Oncology, 2023, 28 : 941 - 955
  • [6] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
    Mishima, Saori
    Naito, Yoichi
    Akagi, Kiwamu
    Hayashi, Naomi
    Hirasawa, Akira
    Hishiki, Tomoro
    Igarashi, Ataru
    Ikeda, Masafumi
    Kadowaki, Shigenori
    Kajiyama, Hiroaki
    Kato, Motohiro
    Kenmotsu, Hirotsugu
    Kodera, Yasuhiro
    Komine, Keigo
    Koyama, Takafumi
    Maeda, Osamu
    Miyachi, Mitsuru
    Nishihara, Hiroshi
    Nishiyama, Hiroyuki
    Ohga, Shouichi
    Okamoto, Wataru
    Oki, Eiji
    Ono, Shigeru
    Sanada, Masashi
    Sekine, Ikuo
    Takano, Tadao
    Tao, Kayoko
    Terashima, Keita
    Tsuchihara, Katsuya
    Yatabe, Yasushi
    Yoshino, Takayuki
    Baba, Eishi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (10) : 1237 - 1258
  • [7] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
    Saori Mishima
    Yoichi Naito
    Kiwamu Akagi
    Naomi Hayashi
    Akira Hirasawa
    Tomoro Hishiki
    Ataru Igarashi
    Masafumi Ikeda
    Shigenori Kadowaki
    Hiroaki Kajiyama
    Motohiro Kato
    Hirotsugu Kenmotsu
    Yasuhiro Kodera
    Keigo Komine
    Takafumi Koyama
    Osamu Maeda
    Mitsuru Miyachi
    Hiroshi Nishihara
    Hiroyuki Nishiyama
    Shouichi Ohga
    Wataru Okamoto
    Eiji Oki
    Shigeru Ono
    Masashi Sanada
    Ikuo Sekine
    Tadao Takano
    Kayoko Tao
    Keita Terashima
    Katsuya Tsuchihara
    Yasushi Yatabe
    Takayuki Yoshino
    Eishi Baba
    International Journal of Clinical Oncology, 2023, 28 : 1237 - 1258
  • [8] Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
    Mishima, Saori
    Taniguchi, Hiroya
    Akagi, Kiwamu
    Baba, Eishi
    Fujiwara, Yutaka
    Hirasawa, Akira
    Ikeda, Masafumi
    Maeda, Osamu
    Muro, Kei
    Nishihara, Hiroshi
    Nishiyama, Hiroyki
    Takano, Tadao
    Tsuchihara, Katsuya
    Yatabe, Yasushi
    Kodera, Yasuhiro
    Yoshino, Takayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 217 - 239
  • [9] Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
    Saori Mishima
    Hiroya Taniguchi
    Kiwamu Akagi
    Eishi Baba
    Yutaka Fujiwara
    Akira Hirasawa
    Masafumi Ikeda
    Osamu Maeda
    Kei Muro
    Hiroshi Nishihara
    Hiroyki Nishiyama
    Tadao Takano
    Katsuya Tsuchihara
    Yasushi Yatabe
    Yasuhiro Kodera
    Takayuki Yoshino
    International Journal of Clinical Oncology, 2020, 25 : 217 - 239
  • [10] Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
    Edson, M. A.
    Li, J.
    BREAST DISEASES, 2015, 26 (03): : 223 - 225